Kevin H. Eng

5.8k total citations · 1 hit paper
98 papers, 2.9k citations indexed

About

Kevin H. Eng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Kevin H. Eng has authored 98 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 24 papers in Oncology and 22 papers in Immunology. Recurrent topics in Kevin H. Eng's work include Ovarian cancer diagnosis and treatment (21 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (12 papers). Kevin H. Eng is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (12 papers). Kevin H. Eng collaborates with scholars based in United States, Romania and Canada. Kevin H. Eng's co-authors include Karl Kunzelmann, Dieter C. Gruenert, J. H. Widdicombe, Takashi Ohrui, Alison Cozens, Walter E. Finkbeiner, M J Yezzi, Lawrence S. Chin, Kunle Odunsi and Kayla Morrell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kevin H. Eng

96 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CFTR Expression and Chloride Secretion in Polarized Immortal Human Bronchial Epithelial Cells

1994 814 citations Alison Cozens, M J Yezzi et al. American Journal of Respiratory Cell and Molecular Biology profile →

Peers

Countries citing papers authored by Kevin H. Eng

Since Specialization

Citations

This map shows the geographic impact of Kevin H. Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin H. Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin H. Eng more than expected).

Fields of papers citing papers by Kevin H. Eng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin H. Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin H. Eng. The network helps show where Kevin H. Eng may publish in the future.

Co-authorship network of co-authors of Kevin H. Eng

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin H. Eng. A scholar is included among the top collaborators of Kevin H. Eng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin H. Eng. Kevin H. Eng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Organoids and derived models to study the microenvironments of bacterial infections 2025 ·Current Opinion in Biomedical Engineering ·(unknown), Kevin H. Eng, Francesco Boccellato, Antonella D’Amore	0
2	Stratification of Patients with Renal Cell Carcinoma by the Abundance of Sarcomatoid Features Reveals Differences in Survival and the Underlying Pathobiology 2024 ·European Urology Oncology ·Nicholas Salgia, (unknown), Lin Wang, (unknown), (unknown), (unknown), Kristopher Attwood, Jorge Daza, Mark D. Long, Kevin H. Eng, Bo Xu, Jason B. Muhitch, Eric Kauffman	3
3	Buffering Mechanism in Aortic Arch Artery Formation and Congenital Heart Disease 2024 ·Circulation Research ·(unknown), (unknown), (unknown), Kevin H. Eng, (unknown), Sophie Astrof	2
4	Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair 2021 ·Communications Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kevin H. Eng, Thomas Melendy, Ben Ho Park, Renuka Iyer, Christos Fountzilas, Andrei V. Bakin	8
5	Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils 2020 ·Cancer Immunology Research ·A. Nazmul H. Khan, Tiffany R. Emmons, Jerry Wong, (unknown), Kelly L. Singel, (unknown), (unknown), Joseph D. Tario, Kevin H. Eng, Kirsten B. Moysich, Kunle Odunsi, Scott I. Abrams, Brahm H. Segal	33
6	Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma 2020 ·Genome Research ·(unknown), (unknown), (unknown), (unknown), H. Carlo Maurer, Kenneth P. Olive, Kevin H. Eng, Michael E. Feigin	46
7	Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study 2019 ·Clinical Cancer Research ·Devalingam Mahalingam, Grey Wilkinson, Kevin H. Eng, Paul Fields, Patrick Raber, Jennifer L. Moseley, (unknown), Matt Coffey, Gerard J. Nuovo, Paweł Kaliński, Bin Zhang, Sukeshi Patel Arora, Christos Fountzilas	142
8	Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service 2019 ·PubMed ·(unknown), Sarah Lynam, Kayla Morrell, Kevin H. Eng, Kristen Starbuck, J. Brian Szender, Emese Zsíros, Peter J. Frederick	4
9	Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study 2018 ·PLoS Genetics ·Kevin H. Eng, J. Brian Szender, (unknown), Jasmine Kaur, Samantha Poblete, Ruea‐Yea Huang, Qianqian Zhu, (unknown), Sebastiano Battaglia, Rikki Cannioto, John J. Krolewski, Emese Zsíros, Peter J. Frederick, Shashikant Lele, Kirsten B. Moysich, Kunle Odunsi	9
10	Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis 2017 ·Leukemia ·Goar Mosoyan, T. Kraus, (unknown), Kevin H. Eng, John D. Crispino, Ronald Hoffman, Camelia Iancu‐Rubin	34
11	Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry 2017 ·Journal of Allergy and Clinical Immunology ·Paul Mayor, Kevin H. Eng, Kelly L. Singel, Scott I. Abrams, Kunle Odunsi, Kirsten B. Moysich, Ramsay Fuleihan, Elizabeth Garabedian, Patricia Lugar, Hans D. Ochs, Francisco A. Bonilla, Rebecca H. Buckley, Kathleen E. Sullivan, Zuhair K. Ballas, Charlotte Cunningham‐Rundles, Brahm H. Segal	154
12	HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer 2016 ·Gynecologic Oncology ·J. Brian Szender, Kevin H. Eng, Junko Matsuzaki, Anthony Miliotto, Sacha Gnjatic, Takemasa Tsuji, Kunle Odunsi	6
13	Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer 2016 ·Scientific Reports ·Brandon-Luke L. Seagle, Kevin H. Eng, (unknown), Monica Dandapani, (unknown), (unknown), Kunle Odunsi, Shohreh Shahabi	21
14	Evaluation of satisfaction with work–life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study 2016 ·Gynecologic Oncology Reports ·J. Brian Szender, K.S. Grzankowski, Kevin H. Eng, Kunle Odunsi, Peter J. Frederick	7
15	TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas 2015 ·Gynecologic Oncology ·Brandon-Luke L. Seagle, Chia‐Ping Huang Yang, Kevin H. Eng, Monica Dandapani, (unknown), Gary L. Goldberg, Kunle Odunsi, Susan Band Horwitz, Shohreh Shahabi	20
16	Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer 2015 ·Gynecologic Oncology ·(unknown), Kevin H. Eng, A. Nazmul H. Khan, K.S. Grzankowski, Kelly L. Singel, Kirsten B. Moysich, Brahm H. Segal	71
17	Differential Antigen Expression Profile Predicts Immunoreactive Subset of Advanced Ovarian Cancers 2014 ·PLoS ONE ·Kevin H. Eng, Takemasa Tsuji	10
18	Estimating Tree-Structured Covariance Matrices via Mixed-Integer Programming 2009 ·International Conference on Artificial Intelligence and Statistics ·Héctor Corrada Bravo, Stephen J. Wright, Kevin H. Eng, Sündüz Keleş, Grace Wahba	2
19	New research on cattle liver abscesses may lead to vaccination 1996 ·Kevin H. Eng	1
20	CFTR Expression and Chloride Secretion in Polarized Immortal Human Bronchial Epithelial Cells breakdown → 1994 ·American Journal of Respiratory Cell and Molecular Biology ·Alison Cozens, M J Yezzi, Karl Kunzelmann, Takashi Ohrui, Lawrence S. Chin, Kevin H. Eng, Walter E. Finkbeiner, J. H. Widdicombe, Dieter C. Gruenert	814

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact